LCTX - Lineage Cell Therapeutics, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Biological Products, (No Diagnostic Substances) - LCTX (876343)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
8 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2024-02-08
LCTXBailey Don MDirP - Purchase$1.04+96,155158,801+153%+$100,001
2024-02-06
LCTXBroadwood Partners, L.P.Dir, 10%P - Purchase$1.04+6,730,77083,420,138+9%+$7,000,001
2023-12-29
LCTXJayasuriya AnulaDirP - Purchase$1.09+10,00010,000New+$10,900
D
2022-03-31
LCTXCulley Brian MPres, CEOP - Purchase$1.53+6,40097,787+7%+$9,792
2022-03-28
LCTXAmin DiptiDirP - Purchase$1.63+35,00035,000New+$57,050
2022-03-25
LCTXCulley Brian MPres, CEOP - Purchase$1.38+5,25081,280+7%+$7,245
M
2022-03-23
LCTXBroadwood Partners, L.P.Dir, 10%P - Purchase$1.42+930,10669,958,598+1%+$1,317,667
2022-03-24
LCTXMulroy Michael H.DirP - Purchase$1.40+7,000258,555+3%+$9,800

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top